Neuroprotective and anti-stress effect of A68930 in acute and chronic unpredictable stress model in rats

Neuroscience Letters

Volumn 504, Issue 2, 2011, Pages 151-155

  Rasheed, Naila ^a,b   Ahmad, Ausaf ^b,c   Al Sheeha, Muneera ^a   Alghasham, Abdullah ^a   Palit, Gautam ^b  

^a QASSIM UNIVERSITY   (Saudi Arabia)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c AMITY UNIVERSITY   (India)

Author keywords

A68930; Acute stress; Chronic unpredictable stress; Dopamine; Glucocorticoid receptor; Tyrosine hydroxylase

Indexed keywords

1 AMINOMETHYL 5,6 DIHYDROXY 3 PHENYLISOCHROMAN; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; DOPAMINE; DOPAMINE 1 RECEPTOR; GLUCOCORTICOID RECEPTOR; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; TYROSINE 3 MONOOXYGENASE;

ACUTE STRESS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; BRAIN NERVE CELL; BRAIN REGION; CHRONIC STRESS; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; EXPERIMENTAL MODEL; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIPID PEROXIDATION; MEDIAL FOREBRAIN BUNDLE; NERVE FIBER; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ACUTE DISEASE; ANIMALS; ANTIOXIDANTS; BRAIN CHEMISTRY; CATALASE; CHROMANS; CHRONIC DISEASE; DOPAMINE AGONISTS; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; NEUROPROTECTIVE AGENTS; RATS; RECEPTORS, GLUCOCORTICOID; STRESS, PSYCHOLOGICAL; SUPEROXIDE DISMUTASE; TYROSINE 3-MONOOXYGENASE;

EID: 80053932959     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.09.021     Document Type: Article

References (32)

1. Aebi H. Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
2. Agrawal A.K., Shukla S., Chaturvedi R.K., Seth K., Srivastava N., Ahmad A., Seth P.K. Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells. Neurobiol. Dis. 2004, 16:516-526.
3. Ahmad A., Rasheed N., Banu N., Palit G. Alterations in monoamine levels and oxidative systems in frontal cortex, striatum, and hippocampus of the rat brain during chronic unpredictable stress. Stress 2010, 13:355-364.
4. Asanuma M., Miyazaki I., Ogawa N. Dopamine- or l-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease. Neurotoxicol. Res. 2003, 5:165-176.
5. Danilczuk Z., Ossowska G., Wrobel A., Lupina T. Glucocorticoids modulate behavioral effects induced by dopaminergic agonists in rats. Pol. J. Pharmacol. 2001, 53:467-473.
6. de Kloet E.R., Reul J.M., Sutanto W. Corticosteroids and the brain. J. Steroid Biochem. Mol. Biol. 1990, 37:387-394.
7. Deroche V., Marinelli M., Maccari S., Le Moal M., Simon H., Piazza P.V. Stress-induced sensitization and glucocorticoids. I. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion. J. Neurosci. 1995, 15:7181-7188.
8. Flohe L., Gunzler W.A. Assays of glutathione peroxidase. Methods Enzymol. 1984, 105:114-121.
9. Jankord R., Herman J.P. Limbic regulation of hypothalamo-pituitary-adrenocortical function during acute and chronic stress. Ann. N. Y. Acad. Sci. 2008, 1148:64-73.
10. Katz R.J., Roth K.A., Caroll B.J. Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci. Biobehav. Rev. 1981, 5:247-251.
11. Kearns C.M., Gash D.M. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 1995, 672:104-111.
12. Le W.D., Jankovic J., Xie W., Appel S.H. Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection. J. Neural. Transm. 2000, 107:1165-1173.
13. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
14. Marti O., Martin M., Gavalda A., Giralt M., Hidalgo J., Hsu B.R., Kuhn R.W., Armario A. Inhibition of corticosteroid-binding globulin caused by a severe stressor is apparently mediated by the adrenal but not by glucocorticoid receptors. Endocrine 1997, 6:159-164.
15. McIntosh L.J., Hong K.E., Sapolsky R.M. Glucocorticoids may alter antioxidant enzyme capacity in the brain: baseline studies. Brain Res. 1998, 791:209-214.
16. Misra H.P., Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 1972, 247:3170-3175.
17. Miyazaki I., Asanuma M. Dopaminergic neuron-specific oxidative stress caused by dopamine itself. Acta Med. Okayama 2008, 62:141-150.
18. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
19. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press. 4th ed.
20. Piazza P.V., Le Moal M. Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res. Rev. 1997, 25:359-372.
21. Piazza P.V., Le Moal M. The role of stress in drug self-administration. Trends Pharmacol. Sci. 1998, 19:67-74.
22. Rai D., Bhatia G., Sen T., Palit G. Comparative study of perturbations of peripheral markers in different stressors in rats. Can. J. Physiol. Pharmacol. 2003, 81:1139-1146.
23. Rasheed N., Ahmad A., Pandey C.P., Chaturvedi R.K., Lohani M., Palit G. Differential response of central dopaminergic system in acute and chronic unpredictable stress models in rats. Neurochem. Res. 2010, 35:22-32.
24. Rasheed N., Ahmad A., Singh N., Singh P., Mishra V., Banu N., Lohani M., Sharma S., Palit G. Differential response of A68930 and sulpiride in stress-induced gastric ulcers in rats. Eur. J. Pharmacol. 2010, 643:121-128.
25. Rastogi R.B., Singhal R.L. Evidence for the role of adrenocortical hormones in the regulation of noradrenaline and dopamine metabolism in certain brain areas. Br. J. Pharmacol. 1978, 62:131-136.
26. Schatzberg A.F., Rothschild A.J., Langlais P.J., Bird E.D., Cole J.O. A corticosteroid/dopamine hypothesis for psychotic depression and related states. J. Psychiatr. Res. 1985, 19:57-64.
27. Sedlak J., Lindsay R.H. Estimation of total, protein-bound, and nonproteinsulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 1968, 25:192-205.
28. Sheikh N., Ahmad A., Siripurapu K.B., Kuchibhotla V.K., Singh S., Palit G. Effect of Bacopa monniera on stress induced changes in plasma corticosterone and brain monoamines in rats. J. Ethnopharmacol. 2007, 111:671-676.
29. Shingo T., Date I., Yoshida H., Ohmoto T. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease. J. Neurosci. Res. 2002, 69:946-954.
30. Tanaka K., Miyazaki I., Fujita N., Haque M.E., Asanuma M., Ogawa N. Molecular mechanism in activation of glutathione system by ropinirole, a selective dopamine D2 agonist. Neurochem. Res. 2001, 26:31-36.
31. Van Craenenbroeck K., De Bosscher K., VandenBerghe W., Vanhoenacker P., Haegeman G. Role of glucocorticoids in dopamine-related neuropsychiatric disorders. Mol. Cell. Endocrinol. 2005, 245:10-22.
32. Yoshioka M., Tanaka K., Miyazaki I., Fujita N., Higashi Y., Asanuma M., Ogawa N. The dopamine agonist cabergoline provides neuroprotection by activation of the glutathione system and scavenging free radicals. Neurosci. Res. 2002, 43:259-267.